Company intelligence / Profile preview

BioDot

Irvine, California, United Statesbiodot.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

BioDot manufactures automated ultra-low volume liquid handling and dispensing systems that are fundamental to the production of diagnostic tests worldwide. Its technologies support R&D through high-volume manufacturing in diagnostics, cytogenetics, life sciences, and medical products. The company’s installed base supports over three billion diagnostic tests annually across more than sixty countries. No clinical trial results as it does not develop therapeutics.

Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Schleicher & Schuell – membrane provider/investor in lateral flow test developmentADS Biotech – co-marketing Cell Writer Workstation in Europe for cytogenetic applications

Beyond the preview

Go deeper on BioDot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDot.

Explore the full profile